Publication | Closed Access

Postoperative dose-dense sequential chemotherapy with epirubicin, paclitaxel and CMF in patients with high-risk breast cancer: safety analysis of the Hellenic Cooperative Oncology Group randomized phase III trial HE 10/00

Breast OncologyOncologyHigh-risk Breast CancerCancer ManagementBreast CancerPharmacotherapySurgerySafety AnalysisCancer TreatmentMedicineRadiation Oncology